2004

Renin-angiotensin system inhibition prevents type 2 diabetes mellitus
AJ. Scheen
- Part 1. A meta-analysis of randomised clinical trials
- Part 2. Overview of physiological and biochemical mechanisms

The ins and outs of mitochondrial dysfunction in NASH
B Fromenty, MA Robin, A Igoudjil, A Mansouri, D Pessayre

Role of the liver in the control of carbohydrate and lipid homeostasis
C Postic, R Dentin, J Girard

Self-monitoring of blood glucose in diabetic patients:
from the least common denominator to the greatest common multiple
L Monnier, C Colette, H Lapinski, H Boniface

Aldosterone and anti-aldosterone effects in cardiovascular diseases and diabetic nephropathy
ML Ambroisine, P Milliez, J Nehme, AL Pasquier, N De Angelis, P Mansier, B Swynghedauw, C Delcayre

Adiposity signals, genetic and body weight regulation in humans
R Cancello*, A Tounian*, Ch Poitou, K ClEment

Metabolism of lipids in human white adipocyte
V Large, O Peroni, D Letexier, H Ray, M Beylot

ADIPOSE TISSUE AND ADIPOKINES : FOR BETTER OR WORSE
M. GUERRE-MILLO

CLINICAL INTEREST OF PPARs LIGANDS
Particular benefit in type 2 diabetes and metabolic syndrome
B. VERGES

2003

LEFT VENTRICULAR DIASTOLIC DYSFUNCTION:
AN EARLY SIGN OF DIABETIC CARDIOMYOPATHY?
B. COSSON, J.P. KERVORKIAN

POSITIVE AND NEGATIVE REGULATION OF GLUCOSE UPTAKE BY HYPEROSMOTIC STRESS
P. GUAL, Y. LE MARCHAND-BRUSTEL, J.F. TANTI

CARDIOVASCULAR RISK IN TYPE 2 DIABETICS AND PHARMACOLOGICAL REGULATION OF MEALTIME GLUCOSE EXCURSIONS
G. PAOLISSO, M.R. RIZZO, M. BARBIERI, D. MANZELLA, E. RAGNO, D. MAUGERI

OXIDATIVE STRESS AS A THERAPEUTIC TARGET IN DIABETES: REVISITING THE CONTROVERSY
N.F. WIEMSPERGER

GENETICS OF COMMON OBESITY AND TYPE 2 DIABETES : PLEASE FORGET DISEASES AND STUDY PATHOGENIC TRAITS
P. BOUGNERES

REVERSE CHOLESTEROL TRANSPORT, HIGH DENSITY LIPOPROTEINS AND HDL CHOLESTEROL : RECENT DATA
A FREDENRICH, P BAYER

SULFONYLUREAS AND CARDIOVASCULAR EFFECTS :
FROM EXPERIMENTAL DATA TO CLINICAL USE.
AVAILABLE DATA IN HUMANS AND CLINICAL APPLICATIONS
J.-P. RIVELINE, N. DANCHIN, F LEDRY, M. VARROUD-VIAL, G CHARPENTIER

THE CHALLENGE OF POORLY CONTROLLED DIABETES MELLITUS
P. HOME

WHAT'S IN A RISK FACTOR? "HE WHO STRIKES THE BALL"
L. CAPRON

LOOKING FOR AN INSULIN PILL? USE THE BRET METHODOLOGY!
T. ISSAD, N. BOUTE, S. BOUBEKEUR, D. LACASA, K; PERNET

2002

NEW ANTIOBESITY AGENTS IN TYPE 2 DIABETES: OVERVIEW OF CLINICAL TRIALS WITH SIBUTRAMINE AND ORLISTAT
A.J. SCHEEN, PH. ERNEST

ORAL ANTI DIABETIC POLYCHEMOTHERAPY IN TYPE 2 DIABETES MELLITUS
H. GIN, V. RIGALLEAU

BETA CELLS IN TYPE 1 DIABETES : VICTIMS OR ACTIVATORS OF T CELL RESPONSE?
C.THIVOLET

THE ORIGIN OF TYPE 1 DIABETES : AN AUTOIMMUNE DISEASE?
C.BOITARD

NATURAL HISTORY, PROGNOSIS, AND MANAGEMENT OF TRANSPLANTATION-INDUCED DIABETES MELLITUS
P.Y BENHAMOU, A. PENFORNIS

MOLECULAR MECHANISMS OF INSULIN-STIMULATED GLUCOSE UPTAKE IN ADIPOCYTES
P.H. DUCLUZEAU, L.M. FLETCHER, H. VIDAL, M. LAVILLE, J.M. TAVARE

SULFONYLUREA RECEPTOR -1 (SUR1): GENETIC AND METABOLIC EVIDENCES FOR A ROLE IN THE SUSCEPTIBILITY TO TYPE 2 DIABETES MELLITUS
A.F. REIS, G.VELHO

DIABETES IN AFRICANS PART 2
E. SOBNGWI, F. MAUVAIS-JARVIS, P. VEXIAU, J.C. MBANYA, J.F. GAUTHIER

2001

EXERCISE HYPOGLYCEMIA IN NONDIABETIC SUBJECTS
J.F. BRUN, M. DUMORTIER, C. FEDOU, J. MERCIER

ENDOTHELIAL DYSFUNCTION AND TYPE 2 DIABETES PART 1
B. GUERCI, A. KEARNEY-SCHWARTZ, P. BOHME, F. ZANNAD, P. DROUIN

ENDOTHELIAL DYSFUNCTION AND TYPE 2 DIABETES PART 2
B. GUERCI, A. KEARNEY-SCHWARTZ, P. BOHME, F. ZANNAD, P. DROUIN

THERAPEUTIC PERSPECTIVES FOR TYPE 2 DIABETES MELLITUS : MOLECULAR AND CLINICAL INSIGHTS
F. MAUVAIS-JARVIS, F. ANDREELLI, H. HANAIRE-BROUTIN, B. CHARBONNEL, J.GIRARD

THIAZOLIDINEDIONES AND LIVER TOXICITY
A.J. SCHEEN

DIABETES IN AFRICANS PART 1
E. SOBNGWI, F. MAUVAIS-JARVIS, P. VEXIAU, J.C. MBANYA, J.F. GAUTHIER

ADVANCED GLYCATION END PRODUCTS, THEIR RECEPTORS AND DIABETIC ANGIOPATHY
J.L. WAUTIER, P.J. GUILLAUSSEAU

2000

CHROMIUM IN THE PREVENTION AND CONTRL OF DIABETES
R.A. ANDERSON

CONSEQUENCES OF THE DIABETIC STATUS ON THE OXIDANT/ANTIOXIDANT BALANCE
D. BONNEFONT-ROUSSELOT, J.P. BASTARD, M.C. JAUDON, J. DELATTRE

POTENTIAL INFLUENCE OF LIPIDS IN DIABETIC NEPHROPATHY : INSIGHTS FROM EXPERIMENTAL DATA AND CLINICAL STUDIES
F. BONNET, M.E. COOPER

POSTPRANDIAL REACTIVE HYPOGLYCEMIA
J.F. BRUN, C. FEDOU, J. MERCIER

POSTPRANDIAL HYPERGLYCEMIA. POSTPRANDIAL HYPERGLYCEMIA AND DIABETES
H. GIN, V. RIGALLEAU

NON-ALCOHOLIC STEATOHEPATITIS : ASSOCIATION WITH OBESITY AND INSULIN RESISTANCE, AND INFLUENCE OF WEIGHT LOSS
F.H. LUYCKX, P.J. LEFEBVRE, A.J. SCHEEN

UNDERSTANDING THE PATHOGENESIS AND TREATMENT OF INSULIN RESISTANCE AND TYPE 2 DIABETES MELLITUS : WHAT CAN WE LEARN FROM TRANSGENIC AND KNOCKOUT MICE ?
F. MAUVAIS-JARVIS, C. RONALD KAHN

BODY FAT DISTRIBUTION, THE MENOPAUSE TRANSITION, AND HORMONE REPLACEMENT THERAPY
A. TCHERNOF, E.T. POEHLMAN, J.P. DESPRES